相关实验视频

Updated: Jul 16, 2025

Methyl-binding DNA capture Sequencing for Patient Tissues

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

低甲基化DRD2通过FLNA-ERK通路促进乳腺癌

Shuoyi Zhang¹, Ming Zhong¹, Hongbo Zhu²

¹Department of Breast Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, China.

Cancer genetics

|September 20, 2023

概括

荷尔蒙受体阴性乳腺癌中多巴胺受体D2 (DRD2) 低甲基化通过FLNA-ERK通路促进细胞增殖和瘤生长. 在DRD2中,DRD2是DRD2.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

多巴胺受体D2 (DRD2) 是一种涉及癌症的干细胞标记物.
激素受体阴性乳腺癌带来了独特的治疗挑战.
表观遗传修饰,如DNA甲基化,在癌症的发展中起着至关重要的作用.

研究的目的:

研究DRD2表达及其促进体甲基化在荷尔蒙受体阴性乳腺癌中的作用.
阐明DRD2在乳腺癌扩散和生长中所影响的分子通路.
评估向DRD2甲基化的治疗潜力.

主要方法:

高通量DNA甲基化测序 (850K芯片) 和酸验证.
免疫组织化学评估DRD2在瘤和正常组织中的表达.
在体外和体内实验评估DRD2功能和信号通路 (FLNA-ERK).

主要成果:

在激素受体阴性乳腺癌中观察到DRD2促进剂低甲基化,与高风险因素相关.
提升DRD2的调控增强了乳腺癌细胞的增殖和瘤的生长 (Ki67,CD31表达).
调节DRD2表达的FLNA-ERK信号通路酸化;甲基化抑制剂部分逆转了DRD2下调效应.

结论:

DRD2促进剂低甲基化是激素受体阴性乳腺癌的标志.
通过FLNA-ERK信号通路,DRD2促进乳腺癌的进展.
针对DRD2甲基化状态及其下游信号通路可能提供新的治疗策略.

关键词:

乳腺癌是什么? 乳腺癌是什么?多巴胺受体的受体是多巴胺受体.通过ERK路径.高通量的高通量.甲基化甲基化甲基化

更多相关视频

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

相关概念视频

Epigenetic Regulation

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...